Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity
If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.This is my first time covering Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) for Seeking Alpha. The San Diego, California-based drug developer completed its initial public o ...